More recent immune-mediated and regenerative paradigms now highlight the complexity of narcolepsy type 1 as an autoimmune disorder and underscore the need for models that faithfully capture narcolepsy type 2, where orexin function is only partially impaired. Here, HCRT is linked to narcolepsy without cataplexy.